Headlines

Implants Show Promise for Treatment of Chronic Eye Inflammation

Published

9 years ago

January 22, 2015

Managing uveitis may get easier.

Modern inflammatory therapy may make it easier for the general ophthalmologist or optometrist to manage uveitis, writes a contributor to Healio. “Implants delivering low but consistent dosing of anti-inflammatories show great promise in early studies for keeping disease under better control,” says Dr. John A. Hovanesian. “Many of these have been developed for the postoperative cataract population or for patients with macular degeneration because these conditions are so common, but they certainly offer promise for uveitis patients, too.”

Read more at Healio

Crizal® Sapphire™ HR: Invisible Shield of Protection

Your patients’ main concerns of anti-glare, scratch resistance, and easiness to clean are covered. Crizal Sapphire HR, the latest and most advanced product in the Crizal No-Glare range, is now widely available across lab networks and through all major managed vision care providers. Crizal Sapphire HR is available with Essilor’s advanced lens designs such as Varilux® progressive lenses and Eyezen® enhanced single vision lenses. Click here to learn more. *External laboratory tests and internal technical tests – 2020. Compared to the competitor most known lens-brands by consumers (2019 external brand tracking in 11 countries). The word ’overall’ refers to anti-reflective coatings important criteria, ranked through an external quantitative consumer study – 2019.